– 2024 sustainability report highlights tangible sustainability gains across emissions, energy, and circularity.
– Sustainable solutions are a key pillar of the corporate strategy.
– EcoVadis platinum rating underscores Syntegon’s leadership in responsible business.
– Ambitious climate commitment: net-ze…

– Joint development with partners from the pharmaceutical industry
– The highest output in the market: up to 600 containers per minute
– Significantly reduced contamination risk thanks to full automation and contactless, suspended transport

At Pharmatag 2025 in Crailsheim, Syntegon presented a new line co…

– 10th edition of Pharmatag with record participation.
– World premiere of SynTiso: innovative line concept for liquid pharmaceutical filling.
– Program presents latest innovations and successful, collaborative partnerships.

On May 20 and 21, 2025, Syntegon, a leading strategic partner to the global pharm…

– New strategy fuels accelerated growth following CEO transition in late 2023
– Order intake increased by 11% to 1.8 billion EUR and revenue grew by 7% to 1.6 billion EUR
– Strong EBITDA improvement by 15% to 222 million EUR and 14% EBITDA margin (up 100 bps)
– Focused cash flow generation program de…

From highly potent to viscous and liquid drugs, pharmaceutical producers and contract manufacturers must fill numerous medicines and suspensions into a wide variety of containers. Choosing the right filling system is crucial for efficient and safe processes. This requires a partner with a broad port…

– 100 percent IPC enables flexible redosing with maximum product yield.
– Gentle processing of up to 400 syringes per minute.
– Combination of proven technologies ensures fast availability and low risk.

Following the first virtual presentation at Interphex, Syntegon is now introducing its new filling mach…

– Räumliche Veränderungen ermöglichen weiteres Wachstum
– Fokussierter Pharma-Standort in Fellbach schafft neue Produktionskapazitäten
– Neues Business Excellence Center in Bad Cannstatt unterstützt weltweite Expansion
– Andreas Stihl AG & Co. KG übernimmt Waiblinger Liegenschaft

Syntegon, ein strategischer Partn…

The market for ready-to-use (RTU) syringes is growing rapidly. In fact, experts anticipate an annual growth rate of about eight percent over the next ten years. In response to this demand, Syntegon has expanded its inspection portfolio with the new AIM DIRect to include integrated de-nesting and re…

– RMA assembly solution for pens and autoinjectors recognized for user-friendliness and seamless processes.
– Design simplifies operations and enables flexible production.
– Long-term value for pharmaceutical manufacturers of, for example, antidiabetics and weight-control products.

Syntegon has received t…

– Eros Carletti joined Syntegon as new CFO effective January 6, 2025
– Peter Hackel resigned on December 31, 2024, after two successful years

The Syntegon Group, a strategic partner to the global pharmaceutical and food industries, has appointed Eros Carletti as new Chief Financial Officer (CFO). He joi…